EUVIMEDEUVIMED entdecken
Crossref

Reverse Lipid Droplet Function for Hepatocellular Carcinoma Immunotherapy

Xuechao Cai, Li Zhang, Ruicheng Shi, Yurong Zhang, Jieyun Shi, Yang Chen, Chaochao Wang, Yi Dai, Lingjiang He, Huiyan Li, Zhixuan Qiu, Xingwu Jiang und 3 weitere

Angewandte Chemie International Edition · 22.01.2026 · 65 (4)

DOI: 10.1002/anie.202520609 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2025-12. Verfasst von Xuechao Cai und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Hepatobiliary and Pancreatic Surgery, Department of Hepatobiliary and Pancreatic Surgery, Shanghai East Hospital, School of Medicine, To…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Immunotherapy, Lipid Droplets. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Program of National Natural Science Foundation of China, Shanghai Science and Technology Innovation Action Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipid droplet (LD)‐mediated organelle interactions promote tumor progression and immune evasion in tumors, but directly targeting LD remains challenging. Here, we developed a strategy to reverse LD function for hepatocellular carcinoma (HCC) immunotherapy. We first established a positive correlation between LD‐related proteins and poor prognosis in HCC patients. We then engineered F127‐modified, linoleic acid (LA)‐capped copper MOF nanoparticles (LCMF NPs). These NPs are recognized by CD36 and internalized into LDs. Whereafter, copper ions catalyze surface LA into radicals via Fenton reaction, triggering a polyunsaturated fatty acid peroxidation cascade. This chemical reaction reverses the protective effect of LDs on organelles into an oxidative damage effect. Mechanistically, this process induces significant DNA damage, upregulating key immunogenic cell death markers HMGB1 and calreticulin. In vivo, reversing LD function reshapes the immunosuppressive tumor microenvironment and inhibits growth of both primary and distant tumors. Overall, this LD functional reversal strategy establishes LD‐organelle networks as viable immunotherapy targets and offers a promising approach for treating metastatic tumors via organelle‐level metabolic disruption.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsImmunotherapyLipid DropletsHumansAnimalsMiceCopperLinoleic AcidMetal-Organic FrameworksTumor Microenvironment

Stichwörter der Autor:innen

Hepatocellular carcinomaImmunotherapyLipid dropletOrganelle crosstalk

Substanzen

CopperLinoleic AcidMetal-Organic Frameworks

Autor:innen und Institutionen

  • Institute of Hepatobiliary and Pancreatic Surgery, Department of Hepatobiliary and Pancreatic Surgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200120, P. R. China.
  • Department of Materials Science and State Key Laboratory of Molecular Engineering of Polymers, Academy for Engineering and Technology, Fudan University, Shanghai, 200438, P. R. China.
  • Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, P. R. China.
  • Department of Hematology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200120, P. R. China.
  • School of Life Sciences and Technology, Tongji University, Shanghai, 200092, P. R. China.

ORCID-Profile: Wenbo Bu

Förderung

  • National Natural Science Foundation of China
  • Key Program of National Natural Science Foundation of China
  • Shanghai Science and Technology Innovation Action Plan
  • Scientific Research Project of Pudong New Area Science and Economic Commission
  • Medical Discipline Construction Program of Shanghai Pudong New Area Health Commission (the Emerging and Interdisciplinary Disciplines Program

Zitieren

APA

Cai, X., Zhang, L., Shi, R., Zhang, Y., Shi, J., Chen, Y., Wang, C., Dai, Y., He, L., Li, H., Qiu, Z., Jiang, X., Wang, J., Wu, Y., & Bu, W. (2026). Reverse Lipid Droplet Function for Hepatocellular Carcinoma Immunotherapy. Angewandte Chemie International Edition, 65(4). https://doi.org/10.1002/anie.202520609

Vancouver

Cai X, Zhang L, Shi R, Zhang Y, Shi J, Chen Y, et al. Reverse Lipid Droplet Function for Hepatocellular Carcinoma Immunotherapy. Angewandte Chemie International Edition. 2026;65(4). doi:10.1002/anie.202520609

BibTeX
@article{Cai2026,
  author = {Cai, Xuechao and Zhang, Li and Shi, Ruicheng and Zhang, Yurong and Shi, Jieyun and Chen, Yang and Wang, Chaochao and Dai, Yi and He, Lingjiang and Li, Huiyan and Qiu, Zhixuan and Jiang, Xingwu and Wang, Jinghan and Wu, Yelin and Bu, Wenbo},
  title = {Reverse Lipid Droplet Function for Hepatocellular Carcinoma Immunotherapy},
  journal = {Angewandte Chemie International Edition},
  year = {2026},
  volume = {65},
  number = {4},
  doi = {10.1002/anie.202520609}
}
Kostenlos starten →